18 April 2018
Researchers from the Massachusetts Institute of Technology (MIT) have created a computer algorithm to develop artificial peptides to tackle drug-resistant bacterial infections.
17 April 2018
Researchers at the University of Alberta (UAlberta) have devised a new method to significantly increase the accuracy of gene-editing technology, taking it ‘one step closer’ to application in patients.
12 April 2018
Symcel has announced it is partnering with Karolinska Institutet to validate calScreener in clinical antimicrobial susceptibility testing.
5 April 2018
Eli Lilly and Sigilon Therapeutics have announced a strategic collaboration to develop encapsulated cell therapies for type 1 diabetes.
28 March 2018
Researchers from the Institute of Cancer Research (ICR) in the UK have developed a computerised cell model of tumours to predict the treatment response to a new tumour-heating technology against...
23 March 2018
A new study conducted by Oracle Health Sciences and Informa Engage/Pharma Intelligence has showed that 62% of drug safety experts prefer using artificial intelligence (AI) for adverse event (AE) processing.
21 March 2018
The UK has signed the European X-Ray Free-Electron Laser (XFEL) convention in Berlin, Germany.
19 March 2018
Biodata company CytoReason has used artificial intelligence (AI) to predict whether patients will respond to anti-tumour necrosis factor (TNF) alpha drugs.
15 March 2018
US-based drug development consultancy Certara has launched a consortium to assess various treatments, their dose regimes and disease biomakers.
14 March 2018
AbCellera Biologics has received a four-year contract from the US Defense Advanced Research Projects Agency (DARPA) for the development of a rapid response platform against viral pandemics.